SEC Filing Summary: Amedica Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on November 6, 2014. The report discloses the issuance of a press release announcing financial results for the third quarter of fiscal year 2014. The registrant is incorporated in Delaware with principal executive offices in Salt Lake City, Utah.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a notification that these results were announced in a press release attached as Exhibit 99.1, which is incorporated by reference but not detailed within the body of this 8-K.
Material Changes
No specific material changes versus the prior comparable period are quantified in this filing text. The report indicates that the company has released Q3 2014 results, but the magnitude of any changes is contained within the referenced press release.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information contained in the press release (Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor subject to the liabilities of that Section. No specific guidance, outlook, or risk factors are detailed in the text of this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 6, 2014) for actual Q3 2014 financial figures.
- Verify the discrepancy between the metadata company name ("Sintx Technologies, Inc.") and the registrant name in the filing ("Amedica Corporation").
- Confirm the fiscal year end date to ensure accurate period comparison.
- Check for any subsequent filings that may provide updated liquidity or debt positions.